James R. Gruber - Net Worth and Insider Trading

James R. Gruber Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James R. Gruber owns 1 companies in total, including Eton Pharmaceuticals Inc (ETON) .

Click here to see the complete history of James R. Gruber’s form 4 insider trades.

Insider Ownership Summary of James R. Gruber

Ticker	Company	Transaction Date	Type of Owner
ETON	Eton Pharmaceuticals Inc	2022-04-11	Chief Financial Officer

James R. Gruber Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James R. Gruber Ownership Network

Ownership Network List of James R. Gruber

No Data

Ownership Network Relation of James R. Gruber

James R. Gruber Owned Company Details

What does Eton Pharmaceuticals Inc do?

Who are the key executives at Eton Pharmaceuticals Inc?

James R. Gruber is the Chief Financial Officer of Eton Pharmaceuticals Inc. Other key executives at Eton Pharmaceuticals Inc include Chief Business Officer David Krempa , 10 percent owner Opaleye Management Inc. , and director & President & CEO Sean Brynjelsen .

Eton Pharmaceuticals Inc (ETON) Insider Trades Summary

Over the past 18 months, James R. Gruber made no insider transaction in Eton Pharmaceuticals Inc (ETON). Other recent insider transactions involving Eton Pharmaceuticals Inc (ETON) include a net purchase of 187,500 shares made by Opaleye Management Inc. , a net sale of 210,000 shares made by Sean Brynjelsen , and a net sale of 34,000 shares made by David Krempa .

In summary, during the past 3 months, insiders sold 244,000 shares of Eton Pharmaceuticals Inc (ETON) in total and bought 7,930 shares, with a net sale of 236,070 shares. During the past 18 months, 244,000 shares of Eton Pharmaceuticals Inc (ETON) were sold and 187,500 shares were bought by its insiders, resulting in a net sale of 56,500 shares.

Eton Pharmaceuticals Inc (ETON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eton Pharmaceuticals Inc Insider Transactions

No Available Data

James R. Gruber Mailing Address

Above is the net worth, insider trading, and ownership report for James R. Gruber. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, James R. Gruber's mailing address is: Libertyville Il 60048.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.